Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Medical Genetics · Familial Hypomagnesemia with Secondary Hypocalcemia

Lab Tests & Genetic Testing: Understanding Your Child's Report

At a Glance

Familial hypomagnesemia with secondary hypocalcemia is supported by profoundly low magnesium, low calcium, and low or inappropriately normal PTH. A low FEMg suggests the kidneys are conserving magnesium, while two pathogenic or likely pathogenic TRPM6 variants can confirm the inherited diagnosis.

Navigating the laboratory and genetic reports for Familial hypomagnesemia with secondary hypocalcemia (HSH) can feel like learning a new language. These reports provide the evidence needed to distinguish HSH from more common conditions like epilepsy or primary parathyroid disorders. To confirm a diagnosis of HSH, doctors look for a specific “fingerprint” in the blood, urine, and DNA [1][2].

The Biochemical Profile of HSH

When a child has untreated HSH, their blood work typically shows a very specific pattern. Understanding these markers helps explain why the body is struggling. However, clinicians must interpret these together, as no single test is perfect:

  • Magnesium (Mg): In HSH, magnesium is “profoundly” low [2]. This is the primary driver of all other symptoms.
  • Calcium (Ca): This is also low, which is why HSH is often misdiagnosed as a calcium disorder [1][3].
  • Parathyroid Hormone (PTH): This hormone is usually low or “inappropriately normal” [1]. Normally, when calcium is low, PTH should be very high to fix it. In HSH, the low magnesium prevents the body from making or responding to PTH [4].
  • Phosphorus (Phos): This is typically normal or slightly high, which helps differentiate HSH from other bone-related disorders [1].
  • Vitamin D: Levels of 25-hydroxyvitamin D are usually normal or even high, ruling out nutritional rickets as the primary cause [1].

The FEMg Test: Checking the Kidneys

One of the most important tools in an HSH diagnosis is the Fractional Excretion of Magnesium (FEMg). This is not a single blood test but a calculation that compares the amount of magnesium in the blood to the amount being lost in the urine [5].

To get an accurate result, doctors must collect a blood sample and a urine sample at the same time. In a child with severe magnesium deficiency from HSH, the kidneys are working perfectly—they see the body is starving for magnesium and try to save every bit of it. Therefore, the FEMg in an HSH patient is typically 2% or lower [2][1].

  • If FEMg is <= 2%: This indicates the magnesium is being conserved by the kidneys, supporting an extrarenal loss like the gut [2].
  • If FEMg is > 4%: This suggests the kidneys are “wasting” magnesium, which points toward a different genetic kidney condition rather than HSH [6].

Clinical Caveat: A low FEMg mainly shows that the kidneys are conserving magnesium and does not by itself establish HSH. Interpretation depends on age, kidney function, and other clinical context, requiring cautious clinician interpretation.

Genetic Testing: The Definitive Answer

While blood and urine tests point to HSH, genetic testing of the TRPM6 gene provides the final confirmation. Because HSH is an autosomal recessive condition, the report must ideally show two pathogenic or likely pathogenic mutations (one from each parent) [7][8].

Types of Genetic Analysis

Standard genetic “sequencing” (reading the DNA code like a book) is the first step, but it doesn’t always catch everything. A complete report should consider:

  1. Sequencing: Looks for “spelling errors” in the 39 sections (exons) of the TRPM6 gene [9].
  2. Deletion/Duplication Analysis (MLPA): This looks for missing “pages” or “chapters” of the gene. Some children have HSH because a large chunk of the gene is entirely absent, which standard sequencing can miss [4][10].
  3. Splice-Site Analysis: This checks the “punctuation” between the gene’s sections. If this is broken, the body cannot assemble the magnesium channel correctly [4][10].

Parental Segregation Testing

Once a mutation is found in the child, doctors often perform parental segregation testing [11]. This simply means testing both parents to ensure each one carries one of the child’s mutations. This confirms that the child inherited the condition “in trans” (one from mom and one from dad), which is the hallmark of a recessive genetic diagnosis [4][8]. A negative panel does not necessarily exclude HSH if the phenotype is strong, and a Variant of Uncertain Significance (VUS) requires further interpretation by a genetics professional.

Lab Report Completeness Checklist

Use this list to ensure your child has had a comprehensive diagnostic workup:

  • [ ] Paired Blood and Urine: Were serum and urine magnesium/creatinine collected simultaneously?
  • [ ] FEMg Calculation: Is the FEMg recorded? (Target for HSH is typically ≤2%) [2].
  • [ ] Comprehensive Genetic Panel: Did the test include both sequencing and deletion/duplication analysis for the TRPM6 gene? [4].
  • [ ] PTH Level: Was the Parathyroid Hormone level checked while calcium was low? [1].
  • [ ] Kidney Function: Was creatinine or eGFR checked? (Kidney health affects how we interpret the FEMg) [12].
  • [ ] Medication Review: Was the child taking any diuretics or other medications that could interfere with magnesium levels during testing? [13].

Common questions in this guide

What lab pattern is typical of familial hypomagnesemia with secondary hypocalcemia?
Untreated HSH typically causes profoundly low magnesium, low calcium, and a low or inappropriately normal parathyroid hormone (PTH) level. Phosphorus is usually normal or slightly high, and 25-hydroxyvitamin D is usually normal or high. Doctors interpret the whole pattern because no single result confirms HSH.
What does the FEMg result mean in a child being evaluated for HSH?
FEMg is a calculation using blood and urine magnesium and creatinine collected at the same time. A result of 2% or lower suggests that the kidneys are conserving magnesium and supports loss outside the kidneys; a result above 4% suggests kidney magnesium wasting. Age, kidney function, and medicines can change interpretation, and FEMg alone does not diagnose HSH.
What should TRPM6 genetic testing include?
Testing usually begins with sequencing of the TRPM6 gene, which looks for small DNA changes. A comprehensive evaluation may also include deletion and duplication testing, such as MLPA, and assessment of splice-site changes because standard sequencing can miss larger or certain nonstandard changes. The report should state which methods were used.
How many TRPM6 mutations are needed to support an HSH diagnosis?
Because HSH is inherited in an autosomal recessive pattern, the strongest genetic confirmation is two pathogenic or likely pathogenic TRPM6 variants, with one inherited from each parent. A negative panel does not necessarily rule out HSH when the laboratory and clinical pattern is strong. A variant of uncertain significance should be reviewed by a genetics professional rather than treated as a confirmed diagnosis.
Why might both parents have genetic testing after a child's result?
Parental segregation testing checks whether each parent carries one of the child's TRPM6 variants. Finding one variant from each parent shows that they came from different copies of the gene, supporting the recessive diagnosis and helping clarify the parents' carrier status.
What should be included in a complete HSH lab workup?
The workup should include blood and urine magnesium and creatinine collected together, an FEMg calculation, calcium and PTH testing, kidney function such as creatinine or eGFR, and a review of medicines that can affect magnesium. Genetic testing should cover TRPM6 sequencing and deletion/duplication analysis. Vitamin D and phosphorus may also help distinguish HSH from other causes of low calcium.

Get notified when new evidence is published on Primary hypomagnesemia with secondary hypocalcemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Clinical Spectrum of Primary Hypomagnesemia with Secondary Hypocalcemia due to TRPM6 Mutation.

    Aftab S, Anjum MN, Aslam N, et al.

    Hormone research in paediatrics 2026; (99(7)):1045-1050 doi:10.1159/000547303.

    PMID: 40853861
  2. 2

    Three cases of hereditary hypomagnesemia with secondary hypocalcemia caused by novel TRPM6 gene mutations and a literature review.

    Yang M, Zheng Z, Shan X, Luo Y

    Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(9)):917-925 doi:10.1515/jpem-2026-0185.

    PMID: 42324811
  3. 3

    Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6.

    Astor MC, Løvås K, Wolff AS, et al.

    Endocrine connections 2015; (4(4)):215-22 doi:10.1530/EC-15-0066.

    PMID: 26273099
  4. 4

    Case Report: A Novel Non-Canonical Splice Site Variant (c.1638+7T>C) in TRPM6 Cause Primary Homagnesemia With Secondary Hocalcemia.

    Song J, Lei J, Zhang J, et al.

    Frontiers in pediatrics 2022; (10()):834241 doi:10.3389/fped.2022.834241.

    PMID: 35692977
  5. 5

    The Effect of Omeprazole on Urinary Magnesium Excretion in Children with Peptic Diseases.

    Famouri F, Tavahen N, Gholami H, et al.

    Journal of research in pharmacy practice 2024; (13(2)):53-57 doi:10.4103/jrpp.jrpp_35_24.

    PMID: 39830949
  6. 6

    Utility of fractional excretion of magnesium in diagnosing renal magnesium wasting in pediatric nephrology practice.

    Awazu M, Matsumura K

    Clinical biochemistry 2024; (131-132()):110807 doi:10.1016/j.clinbiochem.2024.110807.

    PMID: 39059606
  7. 7

    Intestinal hypomagnesemia in an Iranian patient with a novel TRPM6 variant: a case report and review of the literature.

    Kamali F, Jamee M, Sayer JA, et al.

    CEN case reports 2023; (12(4)):413-418 doi:10.1007/s13730-023-00785-8.

    PMID: 36967423
  8. 8

    Case Report: Novel TRPM6 Mutations Cause Hereditary Hypomagnesemia With Secondary Hypocalcemia in a Chinese Family and a Literature Review.

    Han Y, Zhao Y, Wang H, Huo L

    Frontiers in pediatrics 2022; (10()):912524 doi:10.3389/fped.2022.912524.

    PMID: 35903165
  9. 9

    Long-term Clinical Follow-up of Patients with Familial Hypomagnesemia with Secondary Hypocalcemia

    Bayramoğlu E, Keskin M, Aycan Z, et al.

    Journal of clinical research in pediatric endocrinology 2021; (13(3)):300-307 doi:10.4274/jcrpe.galenos.2021.2020.0192.

    PMID: 33565749
  10. 10

    A functional study for verifying the pathogenicity of a TRPM6 variant of uncertain significance: A novel non-canonical splicing-site variant in primary hypomagnesemia with secondary hypocalcemia.

    Wang P, Qian Y, Gu C, et al.

    Clinica chimica acta; international journal of clinical chemistry 2021; (523()):469-475 doi:10.1016/j.cca.2021.10.033.

    PMID: 34755648
  11. 11

    Familial hypomagnesemia with secondary hypocalcemia: a novel TRPM6 mutation associated with treatment-resistant migraine in a North African family.

    Paola PM, Gianni C, Emanuele M, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(10)).

    PMID: 42830330
  12. 12

    Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease.

    Grigore TV, Zuidscherwoude M, Witasp A, et al.

    Frontiers in endocrinology 2022; (13()):1046392 doi:10.3389/fendo.2022.1046392.

    PMID: 36699036
  13. 13

    Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors.

    Ledeganck KJ, Anné C, De Monie A, et al.

    Nutrients 2018; (10(6)) doi:10.3390/nu10060677.

    PMID: 29861470

This page is for informational purposes only and does not constitute medical advice. Your child's healthcare team should interpret the laboratory and genetic results in the context of their care.